CRGX vs. APGE, DNLI, IOVA, TWST, VCEL, IMCR, CGON, ADMA, NVAX, and RXRX
Should you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include Apogee Therapeutics (APGE), Denali Therapeutics (DNLI), Iovance Biotherapeutics (IOVA), Twist Bioscience (TWST), Vericel (VCEL), Immunocore (IMCR), CG Oncology (CGON), ADMA Biologics (ADMA), Novavax (NVAX), and Recursion Pharmaceuticals (RXRX). These companies are all part of the "biological products, except diagnostic" industry.
Apogee Therapeutics (NASDAQ:APGE) and CARGO Therapeutics (NASDAQ:CRGX) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, community ranking, media sentiment, dividends and profitability.
Apogee Therapeutics' return on equity of 0.00% beat CARGO Therapeutics' return on equity.
In the previous week, CARGO Therapeutics had 1 more articles in the media than Apogee Therapeutics. MarketBeat recorded 7 mentions for CARGO Therapeutics and 6 mentions for Apogee Therapeutics. CARGO Therapeutics' average media sentiment score of 1.02 beat Apogee Therapeutics' score of 0.47 indicating that Apogee Therapeutics is being referred to more favorably in the media.
Apogee Therapeutics presently has a consensus price target of $73.00, indicating a potential upside of 59.95%. CARGO Therapeutics has a consensus price target of $29.00, indicating a potential upside of 52.63%. Given CARGO Therapeutics' higher probable upside, equities research analysts clearly believe Apogee Therapeutics is more favorable than CARGO Therapeutics.
Apogee Therapeutics received 10 more outperform votes than CARGO Therapeutics when rated by MarketBeat users.
79.0% of Apogee Therapeutics shares are owned by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are owned by institutional investors. 36.1% of Apogee Therapeutics shares are owned by company insiders. Comparatively, 1.4% of CARGO Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Apogee Therapeutics beats CARGO Therapeutics on 6 of the 10 factors compared between the two stocks.
Get CARGO Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CRGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CARGO Therapeutics Competitors List
Related Companies and Tools
